Related Experiment Video
Updated: Jul 9, 2026

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Suppression of TGF-beta signaling by phospholipase D
Noga Gadir1, Evan Lee, Avalon Garcia
1Department of Biological Sciences, Hunter College of the City University of New York, 695 Park Avenue, New York, New York 10021, USA.
Abstract:
MDA-MB-231 human breast cancer cells have a survival signal generated by phospholipase D (PLD) that involves the activation of mTOR and MAP kinase. TGF-beta signals that block cell cycle progression in G(1) are suppressed in MDA-MB-231 cells. We report here that the elevated PLD activity in MDA-MB-231 cells suppresses TGF-beta signaling. Suppression of PLD activity or PLD expression resulted in increased phosphorylation of Smad2 and Smad3 on Ser 465/467-sites on Smads that get phosphorylated by the TGF-beta receptor and positively regulate TGF-beta signaling. The effect of PLD suppression on Smad2/3 phosphorylation was dependent on the presence of TGF-beta. Suppression of PLD also suppressed phosphorylation of Smad2 on Ser 245/250/255-sites that are phosphorylated by MAP kinase and negatively regulate TGF-beta signaling. Suppression of PLD also led to increased expression of the cyclin-dependent kinase (CDK) inhibitors p21Cip1 and p27Kip1, the expression of which is stimulated in response to TGF-beta. Consistent with the elevated expression of CDK inhibitors, suppression of PLD also suppressed phosphorylation of the CDK substrate pRb. Similar effects were also seen in PANC-1 human pancreatic cancer cells. The data presented here indicate that the suppressed TGF-beta signaling in MDA-MB-231 and perhaps many other human cancer cells is due to elevated PLD activity and mediated by mTOR and MAP kinase. These results indicate that the survival signals generated by PLD involve the suppression TGF-beta signals that promote G(1) arrest.
Insights
Elevated phospholipase D (PLD) activity in cancer cells suppresses tumor-suppressing TGF-beta signals. Inhibiting PLD restores TGF-beta signaling, potentially offering new therapeutic strategies for breast and pancreatic cancers.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- MDA-MB-231 breast cancer cells exhibit a survival signal driven by phospholipase D (PLD), involving mTOR and MAP kinase activation.
- Transforming growth factor-beta (TGF-beta) signaling, which normally inhibits cell cycle progression, is suppressed in these cells.
Purpose of the Study:
- To investigate the role of elevated phospholipase D (PLD) activity in suppressing TGF-beta signaling in MDA-MB-231 and PANC-1 cancer cells.
- To elucidate the downstream mechanisms by which PLD impacts TGF-beta pathway components and cell cycle regulators.
Main Methods:
- Suppression of PLD activity and/or expression in cancer cell lines.
- Analysis of Smad2 and Smad3 phosphorylation at sites regulated by TGF-beta receptor and MAP kinase.
- Assessment of cyclin-dependent kinase (CDK) inhibitor expression (p21Cip1, p27Kip1) and pRb phosphorylation.
Main Results:
- Suppression of PLD activity increased Smad2/3 phosphorylation at TGF-beta receptor-regulated sites, dependent on TGF-beta presence.
- PLD suppression decreased Smad2 phosphorylation at MAP kinase-regulated sites.
- Inhibition of PLD led to increased expression of CDK inhibitors p21Cip1 and p27Kip1 and decreased pRb phosphorylation.
Conclusions:
- Elevated PLD activity in MDA-MB-231 and PANC-1 cells suppresses TGF-beta signaling, contributing to cancer cell survival.
- The PLD-mediated suppression of TGF-beta signaling is linked to mTOR and MAP kinase pathways.
- Targeting PLD could restore TGF-beta-induced G(1) arrest, offering a potential therapeutic strategy.
Related Concept Videos
TGF - β Signaling Pathway
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
IP3/DAG Signaling Pathway
Hedgehog Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
